The Lingguizhugan decoction can reduce the serum levels of IL-6, IL-18, and TNF-α in patients with HF, increase the levels of CD3+T, CD4+T, and CD4+T/CD8+T, and improve the cardiac function and clinical symptoms of patients by regulating immunity and inhibiting inflammatory response (141). This evidence concerns the gene CD4 and hydrops fetalis.